Drug Shortage Report for HAVRIX 1440

Last updated on 2020-04-22 History
Report ID 103046
Drug Identification Number 02187078
Brand name HAVRIX - SUS IM 1440 ELISA UNITS/ML
Common or Proper name hepatitis A vaccine, inactivated
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 1440UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's (prefilled syringe / seringue préremplie)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-01-06
Estimated end date Unknown
Actual end date 2020-04-21
Shortage status Resolved
Updated date 2020-04-22
Company comments Supply unavailable in the private market. Supply available for public programs.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-10 English Compare
v2 2020-01-10 French Compare
v3 2020-02-03 English Compare
v4 2020-02-03 French Compare
v5 2020-02-28 English Compare
v6 2020-02-28 French Compare
v7 2020-03-13 English Compare
v8 2020-03-13 French Compare
v9 2020-04-22 English Compare
v10 2020-04-22 French Compare

Showing 1 to 10 of 10